Identificador persistente para citar o vincular este elemento: http://hdl.handle.net/10553/69892
Campo DC Valoridioma
dc.contributor.authorBazal, P.en_US
dc.contributor.authorGea, A.en_US
dc.contributor.authorMartínez-González, M. A.en_US
dc.contributor.authorSalas-Salvadó, J.en_US
dc.contributor.authorAsensio, E. M.en_US
dc.contributor.authorMuñoz-Bravo, C.en_US
dc.contributor.authorFiol, M.en_US
dc.contributor.authorMuñoz, M. A.en_US
dc.contributor.authorLapetra, J.en_US
dc.contributor.authorSerra-Majem, L. L.en_US
dc.contributor.authorPintó, X.en_US
dc.contributor.authorGonzález, J. I.en_US
dc.contributor.authorBecerra-Tomás, N.en_US
dc.contributor.authorFitó, M.en_US
dc.contributor.authorRos, E.en_US
dc.contributor.authorAlonso-Gómez, A.en_US
dc.contributor.authorRuiz-Canela, M.en_US
dc.date.accessioned2020-02-05T12:51:03Z-
dc.date.accessioned2020-04-27T16:12:50Z-
dc.date.available2020-02-05T12:51:03Z-
dc.date.available2020-04-27T16:12:50Z-
dc.date.issued2019en_US
dc.identifier.issn0939-4753en_US
dc.identifier.otherScopus-
dc.identifier.urihttp://hdl.handle.net/10553/69892-
dc.description.abstractThere is ongoing controversy about the effect of a low to moderate alcohol consumption on atrial fibrillation (AF). Our aim is to assess the association between adherence to a Mediterranean alcohol drinking pattern and AF incidence. Methods and results: A total 6527 out of the 7447 participants in the PREDIMED trial met our inclusion criteria. A validated frequency food questionnaire was used to measure alcohol consumption. Participants were classified as non-drinkers, Mediterranean alcohol drinking pattern (MADP) (10–30 g/d in men and 5–15 g/day in women, preferably red wine consumption with low spirits consumption), low-moderate drinking (<30 g/day men y and < 15 g/day women), and heavy drinking. We performed multivariable Cox regression models to estimate hazard ratios (HR) with 95% confidence intervals (95% CI) of incident AF according to alcohol drinking patterns. After a mean follow up of 4.4 years, 241 new incident AF cases were confirmed. Alcohol consumption was not associated to AF incidence among low-moderate drinkers (HR: 0.96; 95%CI: 0.67–1.37), adherents to MADP (HR: 1.15 95%CI: 0.75–1.75), or heavy drinkers (HR: 0.92; 95%CI: 0.53–1.58), compared with non-drinkers. Conclusions: In a high cardiovascular risk adult population, a Mediterranean alcohol consumption pattern (low to moderate red wine consumption) was not associated with an increased incidence of AF. Clinical trials: URL: http://www.controlled-trials.com. Unique identifier: ISRCTN35739639.en_US
dc.languageengen_US
dc.relationEfecto de Una Intervención Intensiva de Pérdida de Peso Con Dieta Mediterránea Hipocalórica, Actividad Física y Tratamiento Conductual Sobre la Prevención Primaria Cardiovascular: Ensayo Predimed-Plusen_US
dc.relation.ispartofNutrition, Metabolism and Cardiovascular Diseasesen_US
dc.sourceNutrition, Metabolism and Cardiovascular Diseases [ISSN 0939-4753], v. 29 (7), p. 676-683en_US
dc.subject3206 Ciencias de la nutriciónen_US
dc.subject241103 Fisiología cardiovascularen_US
dc.subject.otherAlcoholen_US
dc.subject.otherAntioxidanten_US
dc.subject.otherAtrial Fibrillationen_US
dc.subject.otherMediterraneanen_US
dc.subject.otherRed Wineen_US
dc.titleMediterranean alcohol-drinking pattern, low to moderate alcohol intake and risk of atrial fibrillation in the PREDIMED studyen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1016/j.numecd.2019.03.007en_US
dc.identifier.scopus85065191806-
dc.identifier.isi000471141200003-
dc.contributor.authorscopusid57208030943-
dc.contributor.authorscopusid55341244700-
dc.contributor.authorscopusid7004290629-
dc.contributor.authorscopusid7003357665-
dc.contributor.authorscopusid50261129400-
dc.contributor.authorscopusid35201757300-
dc.contributor.authorscopusid7005315313-
dc.contributor.authorscopusid56578057200-
dc.contributor.authorscopusid6507771144-
dc.contributor.authorscopusid57202560799-
dc.contributor.authorscopusid57208932373-
dc.contributor.authorscopusid57192590236-
dc.contributor.authorscopusid56416500800-
dc.contributor.authorscopusid57206229124-
dc.contributor.authorscopusid57202558933-
dc.contributor.authorscopusid7004308784-
dc.contributor.authorscopusid6603417884-
dc.description.lastpage683en_US
dc.identifier.issue7-
dc.description.firstpage676en_US
dc.relation.volume29en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.contributor.daisngid29974706-
dc.contributor.daisngid575410-
dc.contributor.daisngid17754-
dc.contributor.daisngid25605-
dc.contributor.daisngid1313833-
dc.contributor.daisngid4082099-
dc.contributor.daisngid32133951-
dc.contributor.daisngid9921613-
dc.contributor.daisngid34937322-
dc.contributor.daisngid30375249-
dc.contributor.daisngid115192-
dc.contributor.daisngid31338578-
dc.contributor.daisngid4488444-
dc.contributor.daisngid4536729-
dc.contributor.daisngid34944030-
dc.contributor.daisngid28220288-
dc.contributor.daisngid31761100-
dc.description.notasPREDIMED trial was supported by theofficial funding agency for biomedical research of the Spanish government (Instituto de Salud Carlos III) RTICG03/140 (Coordinator: Dr Estruch) and RTIC RD 06/0045(Coordinator: Dr Martínez-González). We also acknowl-edge grants from the National Institutes of Health, UnitedStates (1R01HL118264-01); Fondo de Investigación Sani-tariaeFondo Europeo de Desarrollo Regional (PI04/0233,PI05/0976, PI07/0240, PI10/01407, PI10/02658, PI11/00049,PI11/02505 and AGL2010-22319-C03-03); Consejería deSalud de la Junta de Andalucía (PI0105/2007), and by theGeneralitat Valenciana, Spain (ACOMP/2013/165 andACOMP/2013/159).en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Bazal, R-
dc.contributor.wosstandardWOS:Gea, A-
dc.contributor.wosstandardWOS:Martinez-Gonzalez, MA-
dc.contributor.wosstandardWOS:Salas-Salvado, J-
dc.contributor.wosstandardWOS:Asensio, EM-
dc.contributor.wosstandardWOS:Munoz-Bravo, C-
dc.contributor.wosstandardWOS:Fiol, M-
dc.contributor.wosstandardWOS:Munoz, MA-
dc.contributor.wosstandardWOS:Lapetra, J-
dc.contributor.wosstandardWOS:Serra-Majem, LL-
dc.contributor.wosstandardWOS:Pinto, X-
dc.contributor.wosstandardWOS:Gonzalez, JI-
dc.contributor.wosstandardWOS:Becerra-Tomas, N-
dc.contributor.wosstandardWOS:Fito, M-
dc.contributor.wosstandardWOS:Ros, E-
dc.contributor.wosstandardWOS:Alonso-Gomez, A-
dc.contributor.wosstandardWOS:Ruiz-Canela, M-
dc.date.coverdateJulio 2019en_US
dc.identifier.ulpgces
dc.description.sjr1,111
dc.description.jcr3,7
dc.description.sjrqQ1
dc.description.jcrqQ2
dc.description.scieSCIE
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Nutrición-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Ciencias Clínicas-
crisitem.author.orcid0000-0002-9658-9061-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameSerra Majem, Luis-
crisitem.project.principalinvestigatorSerra Majem, Luis-
Colección:Artículos
Vista resumida

Citas SCOPUSTM   

34
actualizado el 24-nov-2024

Citas de WEB OF SCIENCETM
Citations

30
actualizado el 24-nov-2024

Visitas

133
actualizado el 19-oct-2024

Google ScholarTM

Verifica

Altmetric


Comparte



Exporta metadatos



Los elementos en ULPGC accedaCRIS están protegidos por derechos de autor con todos los derechos reservados, a menos que se indique lo contrario.